Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
.jpg?width=1200)
THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo, according to a study published in the Oct. 31 issue of the New England Journal of Medicine.
Henning Bliddal, M.D., from the Copenhagen University Hospital at Bispebjerg and Frederiksberg in Denmark, and colleagues conducted a 68-week trial at 61 sites in 11 countries. Four hundred seven participants with obesity and a clinical and radiologic diagnosis of moderate knee osteoarthritis with at least moderate pain were randomly assigned to receive once-weekly subcutaneous semaglutide or placebo in a 2:1 ratio in addition to counseling on physical activity and a reduced-calorie diet.
The researchers found that from baseline to week 68, the mean change in body weight was −13.7 and −3.2 percent with semaglutide and placebo, respectively. At week 68, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index pain score was −41.7 and −27.5 points with semaglutide and placebo, respectively. Greater improvement in the 36-Item Short Form Health Survey physical-function score was seen for participants in the semaglutide group versus placebo group (mean change, 12.0 versus 6.5 points). The two groups had a similar incidence of serious adverse events.
"The findings support the use of once-weekly subcutaneous semaglutide at a dose of 2.4 mg for weight management and treatment of pain in persons with obesity and moderate-to-severe pain due to knee osteoarthritis," the authors write.
The study was funded by Novo Nordisk, the manufacturer of semaglutide.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Sugar Consumption Positively Related to Temperature
WEDNESDAY, Sept. 10, 2025 -- Sugar consumption is positively related to temperature, mainly driven by increased intake of sugar-sweetened beverages and frozen desserts, according...
Poor Cardiovascular-Kidney-Metabolic Health Increases Psoriasis Risk
WEDNESDAY, Sept. 10, 2025 -- Poor cardiovascular-kidney-metabolic (CKM) health is associated with an increased risk for psoriasis, especially for those with high genetic risk...
Meal Timing May Shift With Aging, Is Linked to Health Changes
FRIDAY, Sept. 5, 2025 -- Meal timing changes with age and may reflect health changes in older adults, according to a study published online Sept. 4 in Communications...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.